UK Triptan Switch Considered As MHRA Seeks Comment On Imitrex, Zomig
This article was originally published in The Tan Sheet
Executive Summary
UK consumers seeking a triptan for migraine treatment will be questioned by a pharmacist on their history of cardiovascular and cerebrovascular disease prior to purchase if sumatriptan or zolmitriptan are approved for nonprescription sale in the country